BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18089569)

  • 1. Closing the gap on autosomal dominant connexin-26 and connexin-43 mutants linked to human disease.
    Laird DW
    J Biol Chem; 2008 Feb; 283(6):2997-3001. PubMed ID: 18089569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43.
    García IE; Maripillán J; Jara O; Ceriani R; Palacios-Muñoz A; Ramachandran J; Olivero P; Perez-Acle T; González C; Sáez JC; Contreras JE; Martínez AD
    J Invest Dermatol; 2015 May; 135(5):1338-1347. PubMed ID: 25625422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss.
    Press ER; Shao Q; Kelly JJ; Chin K; Alaga A; Laird DW
    J Biol Chem; 2017 Jun; 292(23):9721-9732. PubMed ID: 28428247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal recessive GJA1 (Cx43) gene mutations cause oculodentodigital dysplasia by distinct mechanisms.
    Huang T; Shao Q; MacDonald A; Xin L; Lorentz R; Bai D; Laird DW
    J Cell Sci; 2013 Jul; 126(Pt 13):2857-66. PubMed ID: 23606748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gap junction connexins in female reproductive organs: implications for women's reproductive health.
    Winterhager E; Kidder GM
    Hum Reprod Update; 2015; 21(3):340-52. PubMed ID: 25667189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation.
    Rouan F; White TW; Brown N; Taylor AM; Lucke TW; Paul DL; Munro CS; Uitto J; Hodgins MB; Richard G
    J Cell Sci; 2001 Jun; 114(Pt 11):2105-13. PubMed ID: 11493646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexins: a connection with the skin.
    Richard G
    Exp Dermatol; 2000 Apr; 9(2):77-96. PubMed ID: 10772382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexin26 Mutations Causing Palmoplantar Keratoderma and Deafness Interact with Connexin43, Modifying Gap Junction and Hemichannel Properties.
    Shuja Z; Li L; Gupta S; Meşe G; White TW
    J Invest Dermatol; 2016 Jan; 136(1):225-235. PubMed ID: 26763442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal residues in Cx43 and Cx40 determine physiological properties of gap junction channels, but do not influence heteromeric assembly with each other or with Cx26.
    Gemel J; Lin X; Veenstra RD; Beyer EC
    J Cell Sci; 2006 Jun; 119(Pt 11):2258-68. PubMed ID: 16723732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication.
    Qin H; Shao Q; Curtis H; Galipeau J; Belliveau DJ; Wang T; Alaoui-Jamali MA; Laird DW
    J Biol Chem; 2002 Aug; 277(32):29132-8. PubMed ID: 12042301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice with conditional deletion of Cx26 exhibit no vestibular phenotype despite secondary loss of Cx30 in the vestibular end organs.
    Lee MY; Takada T; Takada Y; Kappy MD; Beyer LA; Swiderski DL; Godin AL; Brewer S; King WM; Raphael Y
    Hear Res; 2015 Oct; 328():102-12. PubMed ID: 26232528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional domain mapping and selective trans-dominant effects exhibited by Cx26 disease-causing mutations.
    Thomas T; Telford D; Laird DW
    J Biol Chem; 2004 Apr; 279(18):19157-68. PubMed ID: 14978038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential potency of dominant negative connexin43 mutants in oculodentodigital dysplasia.
    Gong XQ; Shao Q; Langlois S; Bai D; Laird DW
    J Biol Chem; 2007 Jun; 282(26):19190-202. PubMed ID: 17420259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30.
    Marziano NK; Casalotti SO; Portelli AE; Becker DL; Forge A
    Hum Mol Genet; 2003 Apr; 12(8):805-12. PubMed ID: 12668604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mutations in members of the connexin gene family as a cause of nonsyndromic deafness in Taiwan.
    Yang JJ; Huang SH; Chou KH; Liao PJ; Su CC; Li SY
    Audiol Neurootol; 2007; 12(3):198-208. PubMed ID: 17259707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration.
    Thomas T; Jordan K; Simek J; Shao Q; Jedeszko C; Walton P; Laird DW
    J Cell Sci; 2005 Oct; 118(Pt 19):4451-62. PubMed ID: 16159960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of skin diseases linked to connexin gene mutations.
    Avshalumova L; Fabrikant J; Koriakos A
    Int J Dermatol; 2014 Feb; 53(2):192-205. PubMed ID: 23675785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 gene.
    Lefebvre PP; Van De Water TR
    Brain Res Brain Res Rev; 2000 Apr; 32(1):159-62. PubMed ID: 10928803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution and functional properties of Pelizaeus-Merzbacher-like disease-linked Cx47 mutations on Cx47/Cx47 homotypic and Cx47/Cx43 heterotypic gap junctions.
    Kim MS; Gloor GB; Bai D
    Biochem J; 2013 Jun; 452(2):249-58. PubMed ID: 23544880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bigenic connexin mutations in a patient with hidrotic ectodermal dysplasia.
    Kellermayer R; Keller M; Ratajczak P; Richardson E; Harangi F; Mérei E; Melegh B; Kosztolányi G; Richard G
    Eur J Dermatol; 2005; 15(2):75-9. PubMed ID: 15757815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.